Clearline Capital’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-101,498
| Closed | -$2.27M | – | 107 |
|
|
2023
Q3 | $2.27M | Buy |
101,498
+8,754
| +9% | +$196K | 0.19% | 81 |
|
|
2023
Q2 | $1.99M | Buy |
+92,744
| New | +$1.99M | 0.12% | 74 |
|
|
2022
Q4 | – | Sell |
-153,094
| Closed | -$2.45M | – | 128 |
|
|
2022
Q3 | $2.45M | Hold |
153,094
| – | – | 0.29% | 65 |
|
|
2022
Q2 | $2.71M | Buy |
+153,094
| New | +$2.71M | 0.35% | 60 |
|
|
2020
Q3 | – | Sell |
-44,698
| Closed | -$782K | – | 85 |
|
|
2020
Q2 | $782K | Buy |
+44,698
| New | +$782K | 0.25% | 50 |
|